» Articles » PMID: 23628555

Preconditioning with Sevoflurane Ameliorates Spatial Learning and Memory Deficit After Focal Cerebral Ischemia-reperfusion in Rats

Overview
Specialty Neurology
Date 2013 May 1
PMID 23628555
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have demonstrated that sevoflurane could attenuate cerebral neuron necrosis and apoptosis in ischemia-reperfusion models in rats. The aim of our study was to investigate the effect of preconditioning with sevoflurane on spatial learning and memory ability after focal cerebral ischemia-reperfusion injury in rats and its potential mechanisms. Focal cerebral ischemia was performed via 1h of middle cerebral artery occlusion (MCAO) followed by reperfusion. Before ischemia, rats were subjected to preconditioning with inhalation of 2.4% sevoflurane for 1h. The spatial learning and memory ability of rats was measured by the Morris water maze. The activity of choline acetyltransferase (ChAT) in hippocampus CA1 region was observed by immunohistochemistry method. We found MCAO elicited a significant decrease of the ability of spatial learning and memory in contrast to the sham surgery controls. However, preconditioning with sevoflurane resulted in significantly ameliorates spatial learning and memory deficit induced by MCAO. Furthermore, the number of ChAT positive cells in hippocampus CA1 region in sevoflurane preconditioning group was striking more than that of ischemia-reperfusion group. All results suggested that preconditioning with 2.4% sevoflurane could ameliorate the ability of spatial learning and memory after focal cerebral ischemia-reperfusion in rats via protecting the cholinergic neurons in hippocampal CA1 region.

Citing Articles

Shogaol potentiates sevoflurane mediated neuroprotection against ischemia/reperfusion-induced brain injury via regulating apoptotic proteins and PI3K/Akt/mTOR/s6K signalling and HIF-1α/HO-1 expression.

Jia S, Zhang H, Li L, Wang F, Zhang B Saudi J Biol Sci. 2021; 28(9):5002-5010.

PMID: 34466075 PMC: 8381061. DOI: 10.1016/j.sjbs.2021.07.038.


Sevoflurane alleviates oxygen-glucose deprivation/reoxygenation-induced injury in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway.

Yu Q, Dai H, Jiang Y, Zha Y, Zhang J Exp Ther Med. 2021; 21(4):376.

PMID: 33732349 PMC: 7903476. DOI: 10.3892/etm.2021.9807.


The effect of pre- and after-treatment of sevoflurane on central ischemia tolerance and the underlying mechanisms.

Xu H, Mei X, Xu L J Dent Anesth Pain Med. 2018; 18(1):1-8.

PMID: 29556553 PMC: 5858006. DOI: 10.17245/jdapm.2018.18.1.1.


Effects of TLR3 and TLR9 Signaling Pathway on Brain Protection in Rats Undergoing Sevoflurane Pretreatment during Cardiopulmonary Bypass.

Nan Z, Jin Z, Huijuan C, Tiezheng Z, Keyan C Biomed Res Int. 2018; 2017:4286738.

PMID: 29445737 PMC: 5763070. DOI: 10.1155/2017/4286738.


3,4-oxo-isopropylidene-shikimic acid inhibits cerebral ischemia-induced oxidative stress and neuronal apoptosis in rats.

Tang L, Ye J, Jiang S, Zheng J Am J Transl Res. 2017; 9(4):1764-1773.

PMID: 28469781 PMC: 5411924.